Fig. 1From: Comparing fluorescence-based cell-free assays for the assessment of antioxidative capacity of high-density lipoproteinsDistribution and median values of the antioxidant capacity of HDL as assessed by the DCF assay in apoBd plasma samples of apparently healthy subjects (Controls), patients with cardiovascular disease (CVD patients), patients with high triglyceride levels (High TG patients), and patients with high serum amyloid A levels (High SAA patients). Differences between groups were tested by Mann-Whitney U testBack to article page